Therapeutic Challenges with Catastrophic Antiphospholipid Antibody Syndrome: A Case Report.

antiphospholipid antibody caps

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
16 Sep 2020
Historique:
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

Antiphospholipid antibody syndrome (APS) is a multisystem disorder characterized by thromboembolic events in the presence of antiphospholipid antibodies (APLA). Catastrophic antiphospholipid antibody syndrome (CAPS) is an uncommon variant of APS which is associated with widespread coagulopathy that predominantly affects small vessels. Despite maximal treatment, CAPS has a very high mortality rate. We present a case of a 42-year-old woman with a history of APS who presented to our hospital with complaints of epistaxis, hemoptysis, menorrhagia, and shortness of breath. She was diagnosed with CAPS and developed multiorgan failure and sepsis. Despite maximal treatment with immune modulators, she unfortunately succumbed. With this case, we highlight the importance of early recognition of CAPS and review various treatment modalities that have been proven beneficial. Despite these modalities, CAPS remains a therapeutic challenge in many cases and has a high mortality rate.

Identifiants

pubmed: 33083183
doi: 10.7759/cureus.10482
pmc: PMC7567321
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e10482

Informations de copyright

Copyright © 2020, Harne et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Thromb Haemost. 2006 Feb;4(2):295-306
pubmed: 16420554
Autoimmun Rev. 2014 Jul;13(7):699-707
pubmed: 24657970
Arthritis Rheum. 2002 Apr;46(4):1019-27
pubmed: 11953980
Br J Clin Pharmacol. 2009 Sep;68(3):318-9
pubmed: 19740388
Autoimmun Rev. 2013 Sep;12(11):1085-90
pubmed: 23777822
Arthritis Rheum. 2013 Feb;65(2):464-71
pubmed: 23124321
Semin Thromb Hemost. 2008 Apr;34(3):227-35
pubmed: 18720302
Case Rep Hematol. 2014;2014:704371
pubmed: 25389502
Rheumatology (Oxford). 2016 Feb;55(2):382-4
pubmed: 26472567
J Nephropathol. 2014 Jan;3(1):9-17
pubmed: 24644537
Clin Exp Med. 2019 Aug;19(3):281-288
pubmed: 31214910
Medicine (Baltimore). 2014 Nov;93(26):e143
pubmed: 25474424
Arthritis Rheum. 2006 Aug;54(8):2568-76
pubmed: 16868979
J Clin Rheumatol. 2015 Sep;21(6):311-3
pubmed: 26267719
Case Rep Crit Care. 2016;2016:5375080
pubmed: 27833765
Medicine (Baltimore). 1998 May;77(3):195-207
pubmed: 9653431
Autoimmun Rev. 2016 Dec;15(12):1120-1124
pubmed: 27639837
Medicine (Baltimore). 2001 Nov;80(6):355-77
pubmed: 11704713
Rheumatology (Oxford). 2018 Nov 1;57(11):2055-2057
pubmed: 30101319

Auteurs

Prateek Harne (P)

Internal Medicine, State University of New York (SUNY) Upstate University Hospital, Syracuse, USA.

Parth J Sampat (PJ)

Internal Medicine, State University of New York (SUNY) Upstate University Hospital, Syracuse, USA.

Maneesh Bisen (M)

Internal Medicine, State University of New York (SUNY) Upstate University Hospital, Syracuse, USA.

Jihad BenGabr (J)

Rheumatology, State University of New York (SUNY) Upstate University Hospital, Syracuse, USA.

Hom Neupane (H)

Rheumatology, State University of New York (SUNY) Upstate University Hospital, Syracuse, USA.

Classifications MeSH